[Lys3]-Bombesin

[Lys3]-Bombesin is a GRPR-targeting peptide used in preclinical research for imaging prostate cancer via PET. When conjugated to specific antibodies, it can also direct immune cell-mediated cytotoxicity against small cell carcinoma in experimental models, facilitating both in vitro binding studies and in vivo tumor targeting investigations.